Development of a biomarker signature using grating-coupled fluorescence plasmonic microarray for diagnosis of MIS-C

Development of a biomarker signature using grating-coupled fluorescence plasmonic microarray for diagnosis of MIS-C

Multisystem inflammatory syndrome in children (MIS-C) is a rare but serious condition that can develop 4–6 weeks after a school age child becomes infected by SARS-CoV-2. To date, in the United States more than 8,862 cases of MIS-C have been identified and 72 deaths have occurred. This syndrome typic...

Full description

Bibliographic Details
Main Authors: Michele Maltz-Matyschsyk, Clare K. Melchiorre, Katherine W. Herbst, Alexander H. Hogan, Kristina Dibble, Brandon O’Sullivan, Joerg Graf, Aishwarya Jadhav, David A. Lawrence, William T. Lee, Kyle J. Carson, Justin D. Radolf, Juan C. Salazar, Michael A. Lynes, Connecticut Children’s COVID Collaborative
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Bioengineering and Biotechnology
Subjects:
COVID-19
MIS-C
diagnostic
biomarkers
microarray
Online Access:https://www.frontiersin.org/articles/10.3389/fbioe.2023.1066391/full

Internet

https://www.frontiersin.org/articles/10.3389/fbioe.2023.1066391/full

Similar Items